ImmTOR combined with B cell-targeted therapies provides synergistic activity in mitigating anti-AAV capsid antibody responses and enables repeated vector dosingP. O. Ilyinskii,C. J. Roy,A. M. Michaud,G. L. Rizzo,T. Capela,S. S. Leung, T. K. KishimotoHUMAN GENE THERAPY（2021）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
